276 related articles for article (PubMed ID: 35933572)
1. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic.
Kaufman HW; Chen Z; Niles JK; Radcliff J; Fesko Y
JCO Clin Cancer Inform; 2021 Sep; 5():1028-1033. PubMed ID: 34648367
[TBL] [Abstract][Full Text] [Related]
3. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
Chung A; Chen Q; Curry W; Felix T; Tuan WJ
Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
[TBL] [Abstract][Full Text] [Related]
5. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.
Raffin E; Onega T; Bynum J; Austin A; Carmichael D; Bronner K; Goodney P; Hyams ES
Cancer Epidemiol; 2017 Oct; 50(Pt A):68-75. PubMed ID: 28822325
[TBL] [Abstract][Full Text] [Related]
6. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
Doan C; Li S; Goodwin JS
JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
[TBL] [Abstract][Full Text] [Related]
7. Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database.
Grimm LJ; Lee C; Rosenberg RD; Burleson J; Simanowith M; Fruscello T; Pelzl CE; Friedewald SM; Moy L; Zuley ML
J Am Coll Radiol; 2022 Aug; 19(8):919-934. PubMed ID: 35690079
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
[TBL] [Abstract][Full Text] [Related]
9. Impact of age, race, and family history on COVID-19-related changes in breast cancer screening among the Boston mammography cohort study.
Chen N; Cheng D; Sodipo MO; Barnard ME; DuPre NC; Tamimi RM; Warner ET
Breast Cancer Res Treat; 2023 Nov; 202(2):335-343. PubMed ID: 37624552
[TBL] [Abstract][Full Text] [Related]
10. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
[TBL] [Abstract][Full Text] [Related]
11. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
[TBL] [Abstract][Full Text] [Related]
12. Tomosynthesis Impact on Breast Cancer Screening in Patients Younger Than 50 Years Old.
Rose SL; Shisler JL
AJR Am J Roentgenol; 2018 Jun; 210(6):1401-1404. PubMed ID: 29629810
[TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
[TBL] [Abstract][Full Text] [Related]
14. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + .
Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O
Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175
[TBL] [Abstract][Full Text] [Related]
15. Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
Sprague BL; Nowak SA; Ahern TP; Herschorn SD; Kaufman PA; Odde C; Perry H; Sowden MM; Vacek PM; Weaver DL
Radiol Imaging Cancer; 2024 May; 6(3):e230161. PubMed ID: 38578209
[TBL] [Abstract][Full Text] [Related]
16. Association of time intervals in cancer screenings and older participants' characteristics, in a nationally representative sample.
Razavi M; Bergerot CD; Philip EJ; Dale W
J Geriatr Oncol; 2023 Jan; 14(1):101392. PubMed ID: 36344421
[TBL] [Abstract][Full Text] [Related]
17. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
[TBL] [Abstract][Full Text] [Related]
18. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
[TBL] [Abstract][Full Text] [Related]
19. Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic.
Qian Z; Chen X; Cole AP; Abdollah F; Choueiri TK; Kibel AS; Lipsitz SR; Iyer HS; Trinh QD
Eur Urol Oncol; 2024 Feb; 7(1):151-154. PubMed ID: 37487814
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]